From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

DoD Awards Up to 900M in Medical Countermeasure Contracts

by Global Biodefense Staff
August 18, 2015
Biocoatings Development for Medical Devices

Credit: Shutterstock

The U.S. Department of Defense has recently awarded contracts to several companies in support of Medical Countermeasures Product Research and Development.

The period of performance for the effort is a base period of 5 years with a budget of $500,001,000. Five 1-year option periods, if exercised, could bring the total contract value is $900,000,000.

Task orders can be of the following types and will be determined per requirement at the task order level: Firm Fixed Price, Fixed Price Incentive Fee, Cost Plus Fixed Fee, Cost Plus Incentive Fee, Cost Plus Award Fee, or Time and Materials.

The selected awardees are:

  • Dynport Vaccine Company
  • PPD Development
  • TASC Inc.
  • Leidos Inc.

The overall objective is to facilitate the timely and efficient execution of the U.S. Army’s medical materiel development program by providing a mechanism for advanced medical product development and life cycle support, including pharmaceutical manufacturing and clinical research.

Source: DoD.gov

From Our Partners
Tags: AwardsVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC